Cold-active Enzymes Market Size, Share & Trends Analysis Distribution by Product Type (Proteases, Lipases, Carbohydrases, and Others), Application (Biofuels, Food & Beverages, Detergents, Personal Care & Cosmetics, Textiles, and Others), and By Segments Forecasts, 2025-2034
Global Cold-active Enzymes Market is valued at US$ 365.0 Mn in 2024 and it is expected to reach US$ 553.26 Mn by 2034, with a CAGR of 4.4% during the forecast period of 2025-2034. Cold-active enzymes are specialized proteins produced by microorganisms adapted to permanently cold habitats, including polar regions, deep oceans, and high-altitude environments. These enzymes exhibit high catalytic efficiency at low temperatures, typically between 0&...
Report ID: 3295 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 170
Engineered Enzymes Market Size, Share & Trends Analysis Distribution, By Product (Lipases, Carbohydrase, Polymerases & Nucleases, Proteases, and Others), By Type (Industrial Enzymes and Specialty Enzymes), and By Segments Forecasts, 2025-2034
Global Engineered Enzymes Market Size is valued at US$ 2.6 Bn in 2024 and is predicted to reach US$ 7.3 Bn by the year 2034 at an 11.1% CAGR during the forecast period for 2025-2034. Biologically engineered proteins, known as "engineered enzymes," are created to carry out specific chemical reactions more effectively, selectively, or consistently than their naturally occurring counterparts. Scientists modify an enzyme's amino acid sequence to imp...
Report ID: 3283 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Magnetic Field-Responsive Polymers Market Size, Share & Trends Analysis Distribution by Product Type (Metal-oxide/Ferromagnetic-particle Loaded, Organic/Intrinsically Magnetic Polymer, Metal-ion/Coordination-polymer, and Others), Application (Automotive, Research & Development/Prototyping, Medical & Biomedical Device, Electronics & Printed Electronics, and Others), and Segment Forecasts, 2025-2034
Global Magnetic Field-Responsive Polymers Market Size is valued at US$ 60.0 Mn in 2024 and is predicted to reach US$ 129.4 Mn by the year 2034 at an 8.2% CAGR during the forecast period for 2025-2034. Smart materials designed to alter their chemical or physical characteristics in response to an external magnetic field are known as magnetic field-responsive polymers. These polymers can respond quickly and reversibly to magnetic stimuli because th...
Report ID: 3288 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
DNA Synthesizer Market Size, Share Detailed Report 2026 to 2035
Global DNA Synthesizer Market Size is valued at USD 296.9 Billion in 2024 and is predicted to reach USD 1,278.9 Billion by the year 2034 at a 16.1% CAGR during the forecast period for 2025 to 2034. DNA Synthesizer Market Size, Share & Trends Analysis Report By Type (Benchtop DNA Synthesizers And Large-Scale DNA Synthesizers), Application (Drug Discovery & Development, Genetic Engineering, And Clinical Diagnostics) ...
Report ID: 1912 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Distribution, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes), and Segment Forecasts, 2025-2034
Genomic & Epigenomic Profiling Market Size is valued at US$ 5.5 Bn in 2024 and is predicted to reach US$ 23.2 Bn by the year 2034 at an 15.8% CAGR during the forecast period for 2025-2034. Genomic and epigenomic profiling are advanced analytical approaches used to understand the genetic blueprint of an organism and the regulatory mechanisms that control gene expression. Genomic profiling identifies variations in DNA sequences, such as muta...
Report ID: 3271 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Genome Language Modeling (GLM) Market Size, Share & Trends Analysis Distribution, by Type (Encoder-Based GLMs, Decoder-Based GLMs, and Hybrid/Multimodal GLMs), by Application (Disease Gene Prediction, Variant Pathogenicity Assessment, Functional Genomics Annotation, Clinical Diagnostics, Drug Discovery & Development, and Agricultural Genomics), by End User (Academic & Research Institutes, Pharmaceutical Companies, Hospitals, and Biotech Firms), by Product (Software Tools, Cloud Analytics Platforms, Custom Genomic Models), and Segment Forecasts, 2025-2034
Global Genome Language Modeling (GLM) Market Size is valued at US$ 31.2 Bn in 2024 and is predicted to reach US$ 101.6 Bn by the year 2034 at an 12.9% CAGR during the forecast period for 2025-2034. The study of complex sequences of genetic material is referred to as genome language modeling (GLM), and is a process by means of which we can more accurately determine gene function, recognize mutations, and gain insight into regulatory processes. GL...
Report ID: 3232 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Click Chemistry and Bioorthogonal Chemistry Market Size, Share & Trends Analysis Distribution By Type of Click Chemistry Reaction (CuAAC Reaction, SPAAC Reaction, Diels-Alder Reaction, Thiol-ene Reaction and Other Click Chemistry Reactions), By Type of Molecule (Peptide/Protein, Oligonucleotide Antibody Drug Conjugate, Antibody, Small Molecule, Radiopharmaceutical and Other Molecules), By Application Area (Drug Discovery, Drug Synthesis, and Other Application Areas) and Segment Forecasts, 2025-2034
Click Chemistry and Bioorthogonal Chemistry Market Size is valued at US$ 1.0 Bn in 2024 and is predicted to reach US$ 2.2 Bn by the year 2034 at an 8.1% CAGR during the forecast period for 2025-2034. Click chemistry and bioorthogonal chemistry involve fast, selective, high-yielding reactions that occur under mild, biocompatible conditions, enabling efficient molecular assembly and in vivo labeling without disrupting native biological processes...
Report ID: 3226 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Microbial Fermentation CMO Market Size, Share & Trends Analysis Distribution by Type of Expression System (Bacterial Expression Systems, Yeast Expression Systems and Other Expression Systems), Type of Biologic (Recombinant Proteins, Enzymes, Plasmid DNA, Antibodies and Others), Company Size (Small, Mid-sized, Large and Very Large), End-User (Pharma/Biotech Companies and Academic/ Research Institutes) and Segment Forecasts, 2025-2034
Microbial Fermentation CMO Market Size is valued at US$ 3.9 Bn in 2024 and is predicted to reach US$ 6.4 Bn by the year 2034 at an 5.2% CAGR during the forecast period for 2025-2034. A Microbial Fermentation CMO (Contract Manufacturing Organization) is a specialized partner that produces commercial-scale products—such as therapeutics, enzymes, or food ingredients—using bacteria, yeast, or other microorganisms in large bio...
Report ID: 3194 |
Delivery: Immediate |
Published: September 2025 |
No. of Pages: 180
NGS-Based RNA-Sequencing Market Size, Share & Trends Analysis Distribution by Type (Targeted RNA Sequencing, mRNA Sequencing, Total RNA Sequencing, Single-cell RNA Sequencing (scRNA-Seq), De Novo Transcriptome Assembly , and Non-coding RNA Sequencing (miRNA, lncRNA, circRNA)), Workflow Component, Technology, Application, End-user, and Segment Forecasts, 2025-2034
Global NGS-Based RNA-Sequencing Market Size is valued at US$ 3.6 Bn in 2024 and is predicted to reach US$ 20.3 Bn by the year 2034 at an 19.2% CAGR during the forecast period for 2025-2034. Next-Generation Sequencing (NGS)-based RNA sequencing, or RNA-Seq, is a modern laboratory technique that uses high-throughput sequencing machines to analyze the quantity and sequences of RNA in a biological sample. By converting RNA into DNA and sequencing it...
Report ID: 3186 |
Delivery: Immediate |
Published: September 2025 |
No. of Pages: 180
Residual DNA Testing Market Size, Share & Trends Analysis Distribution by Offering (Product {Consumables, and Instruments & Software}, and Services), by Test Type (Final Product Release Testing, Bulk Lot Release Testing, and Raw Material Testing), By Technology (Polymerase Chain Reaction, Threshold Assay, DNA Probe Hybridization, and Other Technologies), By Application (Monoclonal Antibodies, Cell & Gene Therapy, Vaccines, And Other Applications), By End-User (Pharmaceutical & Biotechnology Companies, CROS & CDMOS, And Academic & Research Institutes) and Segment Forecasts, 2025-2034
Residual DNA Testing Market Size is valued at US$ 0.25 Bn in 2024 and is predicted to reach US$ 0.54 Bn by the year 2034 at an 8.1% CAGR during the forecast period for 2025-2034. Residual DNA testing is a quality control process used in biopharmaceuticals and vaccines to detect, measure, and ensure safe levels of host-cell DNA remaining after production, maintaining product safety, purity, and regulatory compliance standards. Rising biopharmaceu...
Report ID: 3191 |
Delivery: Immediate |
Published: September 2025 |
No. of Pages: 180
Pharmaceuticals